Analysts project U.S. revenue at $419 million, supported by a strong contribution from gRevlimid. The India business is expected to grow 19...

Mayne Pharma sued India's Sun Pharma for allegedly infringing patents on IMVEXXY, a drug for menopause-related vaginal pain. The lawsuit wa...

A massive explosion at a duplex where police were investigating reports of shots fired shook a Washington, D.C, suburb Monday and destroyed...

The Academy of Country Music Honors airs tonight on Fox at 8 p.m. ET, with a line-up of country stars like Carly Pearce, Nelly, and more ta...

Indian drug company Dr Reddy's plans to use its net cash surplus of INR 5,000 crore ($670m) to fund acquisitions and innovations aiming at ...

Under the terms of the agreement, Dr. Reddy’s will acquire the portfolio for an upfront payment of $90 million in cash, contingent payments...

When it comes to hospital stay, a good part of the expense is directly linked to room rent. With time the daily room expenses will go up ma...

Doxycycline Hyclate delayed-release tablets are indicated to reduce the development of drug resistant bacteria.

Film-maker Punit Malhotra has directed the music video with choreography by Paresh.

The remedy requires Teva to divest the drug portfolio to 11 firms and marks the largest drug divestiture order in an FTC pharmaceutical mer...

Convicting the 71-year old Mayne of offences including cheating, criminal conspiray, forgery, the Judge sentenced him to seven years rigoro...

JD(U) nominee Satish Kumar is giving sleepless nights to former Bihar chief minister.

US President Barack Obama may have returned home from Copenhagen with a host of pledges, but he can deliver on his promise only with the ca...

France’s largest pharma company, Sanofi-Aventis, is suing India’s Sun Pharmaceuticals and Hospira’s Mayne Pharma to prevent the latter from...

Ranbaxy Laboratories is planning to launch cardiovascular drug Simvastatin in Australia this year.

One of the biggest trans-continent deals in the generic pharma sector is likely open the floodgates of opportunities for the Indian pharma ...

Continuing with its overseas expansion plans, Ahmedabad-based pharmaceutical firm Claris Lifesciences today said it had entered into strate...